These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 8329994)

  • 1. Unfavorable metabolic milieu in visceral obesity.
    Misra A
    Natl Med J India; 1993; 6(3):135-6. PubMed ID: 8329994
    [No Abstract]   [Full Text] [Related]  

  • 2. [Some biological aspects of obesity].
    Roger P; Crockett R; Luc G; Lespinasse F; Rivière J
    Bord Med; 1970 Mar; 3(3):721-30. PubMed ID: 5422377
    [No Abstract]   [Full Text] [Related]  

  • 3. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.
    Smith SR; Lovejoy JC; Greenway F; Ryan D; deJonge L; de la Bretonne J; Volafova J; Bray GA
    Metabolism; 2001 Apr; 50(4):425-35. PubMed ID: 11288037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Visceral adipose tissue and metabolic syndrome].
    Blüher M; Paschke R
    Dtsch Med Wochenschr; 2003 Oct; 128(44):2319-23. PubMed ID: 14593576
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relation between the abdominal sagittal diameter, fat tissue distribution and metabolic complications].
    Stokić E; Ivković-Lazar T
    Med Pregl; 1996; 49(9-10):365-8. PubMed ID: 8999292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transgenic model of visceral obesity and the metabolic syndrome.
    Masuzaki H; Paterson J; Shinyama H; Morton NM; Mullins JJ; Seckl JR; Flier JS
    Science; 2001 Dec; 294(5549):2166-70. PubMed ID: 11739957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraabdominal obesity and metabolic risk factors].
    von Eyben FE; Mouritsen E; Holm J; Montvilas P; Dimcevski G; Suciu G; Rasmussen IH; Kristensen LL; von Eyben R
    Ugeskr Laeger; 2004 May; 166(23):2262-4. PubMed ID: 15487526
    [No Abstract]   [Full Text] [Related]  

  • 8. Obesity: metabolic aspects.
    Pilkington TR
    Trans Med Soc Lond; 1973; 89():39-41. PubMed ID: 4805629
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipoprotein metabolism in visceral obesity.
    Després JP
    Int J Obes; 1991 Sep; 15 Suppl 2():45-52. PubMed ID: 1794938
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolic difference between visceral fat and subcutaneous abdominal fat].
    Björntorp P
    Diabetes Metab; 2000 Jun; 26 Suppl 3():10-2. PubMed ID: 10945144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes.
    Klöting N; Berndt J; Kralisch S; Kovacs P; Fasshauer M; Schön MR; Stumvoll M; Blüher M
    Biochem Biophys Res Commun; 2006 Jan; 339(1):430-6. PubMed ID: 16298335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype.
    Taksali SE; Caprio S; Dziura J; Dufour S; Calí AM; Goodman TR; Papademetris X; Burgert TS; Pierpont BM; Savoye M; Shaw M; Seyal AA; Weiss R
    Diabetes; 2008 Feb; 57(2):367-71. PubMed ID: 17977954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and the metabolic syndrome.
    Vega GL
    Minerva Endocrinol; 2004 Jun; 29(2):47-54. PubMed ID: 15257255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of weight and distribution of adipose tissue in functional hyperandrogenism].
    Pasquali R; Vicennati V; Gambineri A
    Contracept Fertil Sex; 1998 May; 26(5):372-5. PubMed ID: 9648381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.
    You T; Yang R; Lyles MF; Gong D; Nicklas BJ
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E741-7. PubMed ID: 15562250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6.
    Park HS; Park JY; Yu R
    Diabetes Res Clin Pract; 2005 Jul; 69(1):29-35. PubMed ID: 15955385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obesity and hypertension. Recent advances in etiopathogenesis].
    Cesareo R; Iozzino M; Napolitano C; De Rosa P; De Rosa B; Orsini A
    Recenti Prog Med; 2007; 98(7-8):398-400. PubMed ID: 17685189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral obesity and the heart.
    Mathieu P; Pibarot P; Larose E; Poirier P; Marette A; Després JP
    Int J Biochem Cell Biol; 2008; 40(5):821-36. PubMed ID: 18201922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.